Epicrispr Biotechnologies vs Tolemy Bio
Epicrispr Biotechnologies vs Tolemy Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Tolemy Bio on 46/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 46/100
- agent readiness: 39/100 against 22/100
- headcount: 51 against 4
- funding raised: $90.0M against $1.4M
- LinkedIn following: 7,025 against 1,736
Tolemy Bio
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epicrispr Biotechnologies | Tolemy Bio |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | AI-enabled technology for cell biology research and biopharma development. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Artificial Intelligence, Drug Discovery, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2020 | 2022 |
| Headquarters | South San Francisco, United States | Cambridge, United Kingdom |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Tolemy Bio |
|---|---|---|
| Employees | 51 | 4 |
| Total funding | $90.0M | $1.4M |
| Latest round | Series C | Pre-Seed |
| LinkedIn followers | 7,025 | 1,736 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Tolemy Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 46/100 |
| Traction | 57/100 | 38/100 |
| Team | 40/100 | 70/100 |
| Community | Not published | 15/100 |
| Search visibility | 20/100 | 39/100 |
| Quality | 78/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Tolemy Bio |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Tolemy Bio: common questions
Which is better, Epicrispr Biotechnologies or Tolemy Bio?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 46/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Tolemy Bio compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 46/100), agent readiness (39/100 against 22/100), headcount (51 against 4), funding raised ($90.0M against $1.4M), LinkedIn following (7,025 against 1,736).
Read the full Epicrispr Biotechnologies review and pricing or the Tolemy Bio review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.